Garcia-Yague A, Cuadrado A
Int J Mol Sci. 2023; 24(15).
PMID: 37569656
PMC: 10419244.
DOI: 10.3390/ijms241512280.
Al-Nusaif M, Yang Y, Li S, Cheng C, Le W
Mol Neurodegener. 2022; 17(1):46.
PMID: 35761385
PMC: 9235236.
DOI: 10.1186/s13024-022-00544-w.
Catala-Solsona J, Minano-Molina A, Rodriguez-Alvarez J
Front Mol Neurosci. 2021; 14:786226.
PMID: 34880728
PMC: 8645690.
DOI: 10.3389/fnmol.2021.786226.
Garcia-Yague A, Lastres-Becker I, Stefanis L, Vassilatis D, Cuadrado A
Mol Neurobiol. 2021; 58(12):6697-6711.
PMID: 34609698
PMC: 8639559.
DOI: 10.1007/s12035-021-02558-9.
Jeon S, Yoo A, Chun D, Hong S, Chung H, Kim J
Aging Dis. 2020; 11(3):705-724.
PMID: 32489714
PMC: 7220289.
DOI: 10.14336/AD.2019.0718.
Stem cells and regenerative therapies for Parkinson's disease.
Farrell K, Barker R
Degener Neurol Neuromuscul Dis. 2019; 2:79-92.
PMID: 30890881
PMC: 6065567.
DOI: 10.2147/DNND.S16087.
Efficient Generation of Dopamine Neurons by Synthetic Transcription Factor mRNAs.
Kim S, Lim M, Lee E, Jung S, Chung H, Kim C
Mol Ther. 2017; 25(9):2028-2037.
PMID: 28705346
PMC: 5589083.
DOI: 10.1016/j.ymthe.2017.06.015.
Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment.
Wei X, Gao H, Zou J, Liu X, Chen D, Liao J
Mol Neurobiol. 2015; 53(9):5876-5892.
PMID: 26497037
DOI: 10.1007/s12035-015-9477-7.
Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.
Oh S, Chang M, Song J, Rhee Y, Joe E, Lee H
EMBO Mol Med. 2015; 7(5):510-25.
PMID: 25759364
PMC: 4492814.
DOI: 10.15252/emmm.201404610.
An agarose gel-based neurosphere culture system leads to enrichment of neuronal lineage cells in vitro.
Park K, Nam Y, Choi Y
In Vitro Cell Dev Biol Anim. 2014; 51(5):455-62.
PMID: 25539864
DOI: 10.1007/s11626-014-9855-x.
Telencephalin protects PAJU cells from amyloid beta protein-induced apoptosis by activating the ezrin/radixin/moesin protein family/phosphatidylinositol-3-kinase/protein kinase B pathway.
Yang H, Wu D, Zhang X, Wang X, Peng Y, Hu Z
Neural Regen Res. 2014; 7(28):2189-98.
PMID: 25538739
PMC: 4268718.
DOI: 10.3969/j.issn.1673-5374.2012.028.004.
Nurr1 blocks the mitogenic effect of FGF-2 and EGF, inducing olfactory bulb neural stem cells to adopt dopaminergic and dopaminergic-GABAergic neuronal phenotypes.
Vergano-Vera E, Diaz-Guerra E, Rodriguez-Traver E, Mendez-Gomez H, Solis O, Pignatelli J
Dev Neurobiol. 2014; 75(8):823-41.
PMID: 25447275
PMC: 6584759.
DOI: 10.1002/dneu.22251.
NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.
Decressac M, Volakakis N, Bjorklund A, Perlmann T
Nat Rev Neurol. 2013; 9(11):629-36.
PMID: 24126627
DOI: 10.1038/nrneurol.2013.209.
The N-terminal region of Nurr1 (a.a 1-31) is essential for its efficient degradation by the ubiquitin proteasome pathway.
Alvarez-Castelao B, Losada F, Ahicart P, Castano J
PLoS One. 2013; 8(2):e55999.
PMID: 23409108
PMC: 3567022.
DOI: 10.1371/journal.pone.0055999.
PIASγ enhanced SUMO-2 modification of Nurr1 activation-function-1 domain limits Nurr1 transcriptional synergy.
Arredondo C, Orellana M, Vecchiola A, Pereira L, Galdames L, Andres M
PLoS One. 2013; 8(1):e55035.
PMID: 23358114
PMC: 3554661.
DOI: 10.1371/journal.pone.0055035.
Nuclear import and export signals control the subcellular localization of Nurr1 protein in response to oxidative stress.
Garcia-Yague A, Rada P, Rojo A, Lastres-Becker I, Cuadrado A
J Biol Chem. 2013; 288(8):5506-17.
PMID: 23283970
PMC: 3581400.
DOI: 10.1074/jbc.M112.439190.
Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory.
McNulty S, Barrett R, Vogel-Ciernia A, Malvaez M, Hernandez N, Davatolhagh M
Learn Mem. 2012; 19(12):588-92.
PMID: 23161447
PMC: 3506974.
DOI: 10.1101/lm.026385.112.
Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1.
Lin X, Parisiadou L, Sgobio C, Liu G, Yu J, Sun L
J Neurosci. 2012; 32(27):9248-64.
PMID: 22764233
PMC: 3417246.
DOI: 10.1523/JNEUROSCI.1731-12.2012.
Prospect of cell therapy for Parkinson's disease.
Pawitan J
Anat Cell Biol. 2012; 44(4):256-64.
PMID: 22254154
PMC: 3254879.
DOI: 10.5115/acb.2011.44.4.256.
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease.
Rhee Y, Ko J, Chang M, Yi S, Kim D, Kim C
J Clin Invest. 2011; 121(6):2326-35.
PMID: 21576821
PMC: 3104759.
DOI: 10.1172/JCI45794.